188 related articles for article (PubMed ID: 14695785)
1. Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial.
Lin CY; Bai DJ; Yuan HY; Wang K; Yang GL; Hu MB; Wu ZQ; Li Y
World J Gastroenterol; 2004 Jan; 10(1):136-42. PubMed ID: 14695785
[TBL] [Abstract][Full Text] [Related]
2. Effects of perioperative cimetidine administration on peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: results of a randomized controlled clinical trial.
Li Y; Yang GL; Yuan HY; Bai DJ; Wang K; Lin CR; Hu MB; Feng MH
Hepatogastroenterology; 2005; 52(62):504-8. PubMed ID: 15816467
[TBL] [Abstract][Full Text] [Related]
3. Perioperative cimetidine application modulates natural killer cells in patients with colorectal cancer: a randomized clinical study.
Bai D; Yang G; Yuan H; Li Y; Wang K; Shao H
J Tongji Med Univ; 1999; 19(4):300-3. PubMed ID: 12938523
[TBL] [Abstract][Full Text] [Related]
4. Perioperative cimetidine administration improves systematic immune response and tumor infiltrating lymphocytes in patients with colorectal cancer.
Li B; Cao F; Zhu Q; Li B; Gan M; Wang D
Hepatogastroenterology; 2013; 60(122):244-7. PubMed ID: 22944376
[TBL] [Abstract][Full Text] [Related]
5. Variable natural killer function of tumour-infiltrating lymphocytes from breast carcinomas.
Gudmundsdóttir I; Ogmundsdóttir HM
APMIS; 1992 Aug; 100(8):737-46. PubMed ID: 1325805
[TBL] [Abstract][Full Text] [Related]
6. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.
Wagner P; Koch M; Nummer D; Palm S; Galindo L; Autenrieth D; Rahbari N; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Beckhove P; Weitz J
Ann Surg Oncol; 2008 Aug; 15(8):2310-7. PubMed ID: 18521684
[TBL] [Abstract][Full Text] [Related]
7. Effects of coumarin (1,2-benzopyrone) and cimetidine on peripheral blood lymphocytes, natural killer cells, and monocytes in patients with advanced malignancies.
Marshall ME; Riley LK; Rhoades J; Eichhorn T; Jennings CD; Cibull M; Thompson J
J Biol Response Mod; 1989 Feb; 8(1):62-9. PubMed ID: 2921610
[TBL] [Abstract][Full Text] [Related]
8. Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ.
Koch M; Beckhove P; Op den Winkel J; Autenrieth D; Wagner P; Nummer D; Specht S; Antolovic D; Galindo L; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Weitz J
Ann Surg; 2006 Dec; 244(6):986-92; discussion 992-3. PubMed ID: 17122624
[TBL] [Abstract][Full Text] [Related]
9. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
10. Orally administered streptococcal preparation, OK-432 augments the antitumor immunity of patients with gastric or colorectal cancer.
Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tobe T
Biotherapy; 1990; 2(3):213-22. PubMed ID: 2206774
[TBL] [Abstract][Full Text] [Related]
11. [The effect of cimetidine mainly increases CD4+ cells of peripheral blood T lymphocytes].
Asakage M; Tsuno NH; Kitayama J; Yamada J; Tsuchiya T; Yoneyama S; Takahashi K; Nagawa H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1576-7. PubMed ID: 16315874
[TBL] [Abstract][Full Text] [Related]
12. Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells.
Wang J; Su B; Ding Z; Du X; Wang B
Biochem Biophys Res Commun; 2008 Aug; 372(3):491-6. PubMed ID: 18502198
[TBL] [Abstract][Full Text] [Related]
13. Cimetidine reduces impairment of cellular immunity after cardiac operations with cardiopulmonary bypass.
Katoh J; Tsuchiya K; Osawa H; Sato W; Matsumura G; Iida Y; Suzuki S; Hosaka S; Yoshii S; Tada Y
J Thorac Cardiovasc Surg; 1998 Aug; 116(2):312-8. PubMed ID: 9699585
[TBL] [Abstract][Full Text] [Related]
14. Cimetidine modulates natural killer cell function of patients with chronic lymphocytic leukemia.
Allen JI; Syropoulos HJ; Grant B; Eagon JC; Kay NE
J Lab Clin Med; 1987 Apr; 109(4):396-401. PubMed ID: 3493314
[TBL] [Abstract][Full Text] [Related]
15. Inosine Acedoben Dimepranol promotes an early and sustained increase in the natural killer cell component of circulating lymphocytes: A clinical trial supporting anti-viral indications.
Rumel Ahmed S; Newman AS; O'Daly J; Duffy S; Grafton G; Brady CA; John Curnow S; Barnes NM; Gordon J
Int Immunopharmacol; 2017 Jan; 42():108-114. PubMed ID: 27912146
[TBL] [Abstract][Full Text] [Related]
16. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
[TBL] [Abstract][Full Text] [Related]
17. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract][Full Text] [Related]
18. [Subsets of peripheral blood lymphocytes and tumor infiltrating lymphocytes in cancer patients received chemotherapy].
Mitachi Y; Murakawa Y; Okuno M; Kambe M; Kanamaru R; Takahasi H; Wakui A
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):482-8. PubMed ID: 2138871
[TBL] [Abstract][Full Text] [Related]
19. [Functional and phenotypic analysis of tumor infiltrating lymphocytes derived from solid tumors and effusion associated lymphocytes in malignant ascites cultured in recombinant interleukin 2].
Itoh K; Shiiba K; Ebina N; Anzai R; Ouchi A; Matsuno S
Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):781-90. PubMed ID: 8377752
[TBL] [Abstract][Full Text] [Related]
20. Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes.
Anderson TM; Ibayashi Y; Tokuda Y; Colquhoun SD; Holmes EC; Golub SH
Cancer Res; 1988 Mar; 48(5):1180-3. PubMed ID: 3257716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
